(Q50941006)

25 March 2018

title

Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients. (English)

1 reference

25 March 2018

0 references

G Avellone

1

1 reference

25 March 2018

V di Garbo

2

1 reference

25 March 2018

R Cordova

3

1 reference

25 March 2018

G Rotolo

4

1 reference

25 March 2018

G Raneli

5

1 reference

25 March 2018

R de Simone

6

1 reference

25 March 2018

G Bompiani

7

1 reference

25 March 2018

publication date

1 August 1997

1 reference

25 March 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

25 March 2018

volume

46

1 reference

25 March 2018

issue

8

1 reference

25 March 2018

page(s)

930-934

1 reference

25 March 2018

Mortality among diabetics in a national sample

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

The pathogenesis of atherosclerosis--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Fibrinogen as a risk factor for stroke and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Hypertriglyceridaemia and hypercoagulability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Hypertriglyceridemia and regulation of fibrinolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Association between coagulation factors VII and X with triglyceride rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Hemostatic function in young subjects with central obesity: relationship with left ventricular function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Effectiveness of low-dose heparin in prevention of myocardial reinfarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Hyperglycemia may determine fibrinopeptide A plasma level increase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990082-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(97)90082-2

1 reference

25 March 2018

release_s4omly6afbfhbe3kxzza36aaaa

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s4omly6afbfhbe3kxzza36aaaa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 March 2018